Evidence map›Paper›PMID 37854599›Full record

ArticleFrontiers in immunology2023

Case Report: A

Mingyu Xie, Jingjing Wan, Xin Zheng, Xian Zou, Wanting Chen, Kanglin Zhang, Huiting Yuan, Zhenhong Zhang, Haisheng Zeng

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. [Regulatory mechanisms of post-translational modifications in inflammasome signaling: a review].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mingyu XieDepartment of Pediatric Rheumatology and Immunology, Dongguan Children's Hospital, Dongguan, Guangdong, China.
Jingjing WanDepartment of Pediatric Rheumatology and Immunology, Dongguan Children's Hospital, Dongguan, Guangdong, China.
Xin ZhengDepartment of Pediatric Rheumatology and Immunology, Huizhou Central People's Hospital, Huizhou, Guangdong, China.
Xian ZouDepartment of Pediatric Rheumatology and Immunology, Dongguan Children's Hospital, Dongguan, Guangdong, China.
Wanting ChenDepartment of Pediatric Rheumatology and Immunology, Dongguan Children's Hospital, Dongguan, Guangdong, China.
Kanglin ZhangDepartment of Pediatric Rheumatology and Immunology, Dongguan Children's Hospital, Dongguan, Guangdong, China.
Huiting YuanDepartment of Pediatric Rheumatology and Immunology, Dongguan Children's Hospital, Dongguan, Guangdong, China.
Zhenhong ZhangDepartment of Pediatric Rheumatology and Immunology, Dongguan Children's Hospital, Dongguan, Guangdong, China.
Haisheng ZengDepartment of Pediatric Rheumatology and Immunology, Dongguan Children's Hospital, Dongguan, Guangdong, China.
Dongguan People’s Hospital · CNHuizhou Central People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cryopyrin-associated periodic syndromes (CAPS) have been considered autoinflammatory diseases resulting from Results: A female child carrying a Conclusion: Our study contributes to broadening the clinical spectrum of established pathogenic variants of

Indexed as

Cryopyrin-Associated Periodic SyndromesUrticariaChildEast Asian PeopleFemaleHumansInfant, NewbornMutationNLR Family, Pyrin Domain-Containing 3 ProteinNLR Family, Pyrin Domain-Containing 3 Proteinautoinflammatory diseasemutationnewbornNLRP3NLRP3-AID

Identifiers

PMID37854599
PMCPMC10579556
OpenAlexW4387309478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.